Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Healthcare Services (HCSG) over the last 17 years, with Q4 2025 value amounting to $56.3 million.

  • Healthcare Services' Non-Current Deffered Revenue rose 1252.72% to $56.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $56.3 million, marking a year-over-year increase of 1252.72%. This contributed to the annual value of $56.3 million for FY2025, which is 1252.72% up from last year.
  • As of Q4 2025, Healthcare Services' Non-Current Deffered Revenue stood at $56.3 million, which was up 1252.72% from $55.6 million recorded in Q3 2025.
  • In the past 5 years, Healthcare Services' Non-Current Deffered Revenue registered a high of $56.3 million during Q4 2025, and its lowest value of $31.8 million during Q3 2022.
  • Over the past 5 years, Healthcare Services' median Non-Current Deffered Revenue value was $46.5 million (recorded in 2024), while the average stood at $44.1 million.
  • As far as peak fluctuations go, Healthcare Services' Non-Current Deffered Revenue soared by 5574.46% in 2021, and later tumbled by 3732.24% in 2022.
  • Healthcare Services' Non-Current Deffered Revenue (Quarter) stood at $46.9 million in 2021, then dropped by 27.99% to $33.8 million in 2022, then grew by 21.98% to $41.2 million in 2023, then rose by 21.43% to $50.0 million in 2024, then grew by 12.53% to $56.3 million in 2025.
  • Its Non-Current Deffered Revenue was $56.3 million in Q4 2025, compared to $55.6 million in Q3 2025 and $51.7 million in Q2 2025.